Paolo Piazza– Head of Genomics Facility

Paolo PiazzaPaolo Piazza studied at Universita' degli Studi di Milano, where he completed a degree in Biology and a PhD in Genetics. He joined the Department of Plant Sciences, University of Oxford, in 2003 to work on molecular aspects of evolution of plant shapes. Subsequently, he joined the High Throughput Genomics lab in 2009 within the Wellcome Trust Centre for Human Genetics in Oxford, where he became the section leader for the library preparation team and managed process improvement initiatives for the core. He joined the Imperial BRC Genomics Facility in 2016 as the Head of the Facility.

Anna Zekavati – Genomics Project Manager

Anna ZekavatiAnna Zekavati obtained her MSc in Genetics Manipulation from the University of Sussex and her PhD in Molecular Immunology from the University of Kings College London. She completed a Postdoctoral position at the Institute of Child Health, UCL (University College London), investigating the genetic causes of hypertrophic cardiomyopathy using next generation sequencing. She joined University of Imperial College London in 2012 to set up the Imperial AHSC Clinical Genome Laboratory. That lab subsequently merged with the Imperial BRC Informatics Facility in order to form the existing Imperial BRC Genomics Facility. She has been leading the genomics lab and is currently the genomics project manager of the facility who leads the activities including advising clinical and scientific colleagues in and outside of Imperial College on experimental design of their projects, sample library preparation, sequencing and data delivery, and ensuring that projects are completed on time and within budget.

Rekopoulou, Katerina – Genomics Lab Technician

Katerina graduated from the University of Liverpool with a BSc in Molecular Biology. She then worked at Illumina’s Core Sequencing facility, where she specialized in sample preparation techniques and contributed to the development of a new sample preparation protocol.

Following that, she worked at the MRC Genomics Lab where she gained extensive experience with Next Generation Sequencing platforms for 6 years and finally joined the Imperial BRC Genomics Laboratory in 2018.

Nathalie LambieGenomics Lab Technician

Nathalie LambieNathalie Lambie joined Imperial BRC Genomics Facility, following 8 years of working experience at the MRC Genomics Core Lab where she gained expertise in Next-Generation Sequencing using Illumina MiSeq and HiSeq, microarrays and conventional Sanger sequencing and Genotyping. Prior to this, Nathalie worked at GSK in the RNA Profiling Department focusing primarily on the use of Affymetrix whole genome microarrays and TaqMan real-time quantitative PCR to support pre-clinical and clinical development. Nathalie graduated from the University of Royal Holloway in 2003 with a MSc in Biological Science Research studying the use of PCR to develop microsatellite markers to determine stock structure of southern blue whiting around South America.

Bahar MonibiGenomics Lab Technician

bmBahar Monibi joined the Imperial BRC Genomics Facility as a research technician in January 2017. She has a Master Degree in Molecular Medicine from University College London and a BSc in Biochemistry from the University of Kings College London. She has been trained in various Next Generation Sequencing library preparation techniques and also the operation of Illumina sequencing platforms. Her area of interest is the future use of next generation sequencing approaches in the treatment of human diseases.

Avik Datta – Bioinformatics Programmer

Avik DattaAvik Datta has obtained his Masters degree in Bioinformatics from West Bengal University of Technology, India.  Thereafter, he joined Center for Development of Advanced Computing (C-DAC) , as a Bioinformatician in Pune, India. Later, he got the opportunity to work as part of the Vertebrate Genomics group at EMBL-EBI, UK and carried out his job as a Scientific Programmer. He gained experience in conducting the data coordination activities and developing bioinformatics data analysis pipeline for epigenome consortium project Blueprint. He joined the Imperial BRC Genomics Facility in March 2017 as a Bioinformatics Programmer and presently working on implementing and maintaining the primary data processing pipelines.

Richard Williams- Lead Bioinformatician

Richard Williams joined the Imperial BRC Genomics Facility as Lead Bioinformatician in August 2018. He has a BSc in Biochemistry from Lancaster University, and a PhD from the University of Warwick, where he studied gene regulation in Adenovirus and HIV-1. He continued to work on viral gene regulation as a postdoc at Oxford, then specialised in the genomic correlates of outcome in childhood renal tumours at the Institute of Cancer Research and the UCL Institute of Child Health. At the Genomics Facility, he works on a range of projects requiring custom analysis of sequencing data, and maintains an active collaboration with cancer researchers at UCL.

Vacant - Bioinformatician

Jorge Ferrer – Scientific Lead

Jorge FerrerJorge Ferrer is Chair in Genetics and Medicine, Head of the Section of Epigenomics and Disease, and Theme Leader for Genetics and Genomics in the NIHR Imperial Biomedical Research Centre. He is also a Wellcome Trust Senior Investigator. He received his medical degree and trained in Endocrinology at the University of Barcelona School of Medicine. He subsequently trained in genetics and transcriptional regulation in Washington University and Harvard University before returning to Barcelona in 1997. There he established a research team within Institut d’Investigacions Biomediques August Pi i Sunyer and CIBERDEM, a Spanish diabetes research network. He recently moved to Imperial College London where he has established a laboratory based at Imperial Centre for Translational and Experimental Medicine. Professor Ferrer is interested in understanding genome regulation of pancreatic beta cells and its implications for human diabetes. His team has combined genetic model systems and advanced genomics to address key questions in human beta cell biology, regeneration, and disease.